 | • レポートコード：GIR201103300 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、皮膚筋炎治療薬の世界市場を調査対象にし、皮膚筋炎治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（アバタセプト、バリシチニブ、ダラザチド、免疫グロブリン、IMO-8400、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：MedImmune LLC、Hope Pharmaceuticals Inc、Octapharma AG、Neovacs SA、F. Hoffmann-La Roche Ltd、Novartis AG、KPI Therapeutics Inc、Eli Lilly and Company、Pfizer Inc、Idera Pharmaceuticals Inc、Marathon Pharmaceuticals LLC ・メーカー別販売量、売上、市場シェア ・皮膚筋炎治療薬の地域別市場分析 ・皮膚筋炎治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・皮膚筋炎治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・皮膚筋炎治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・皮膚筋炎治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・皮膚筋炎治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・皮膚筋炎治療薬の種類別市場規模2015-2020：アバタセプト、バリシチニブ、ダラザチド、免疫グロブリン、IMO-8400、その他 ・皮膚筋炎治療薬の用途別市場規模2015-2020：病院、クリニック、その他 ・皮膚筋炎治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Dermatomyositis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Dermatomyositis Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Dermatomyositis Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Dermatomyositis Drug market has been segmented into
Abatacept
Baricitinib
Dalazatide
Immune Globulin
IMO-8400
Others
By Application, Dermatomyositis Drug has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Dermatomyositis Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Dermatomyositis Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Dermatomyositis Drug market.
The report offers in-depth assessment of the growth and other aspects of the Dermatomyositis Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Dermatomyositis Drug Market Share Analysis
Dermatomyositis Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Dermatomyositis Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Dermatomyositis Drug sales, revenue and market share for each player covered in this report.
The major players covered in Dermatomyositis Drug are:
MedImmune LLC
Hope Pharmaceuticals Inc
Octapharma AG
Neovacs SA
F. Hoffmann-La Roche Ltd
Novartis AG
KPI Therapeutics Inc
Eli Lilly and Company
Pfizer Inc
Idera Pharmaceuticals Inc
Marathon Pharmaceuticals LLC
Among other players domestic and global, Dermatomyositis Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dermatomyositis Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dermatomyositis Drug, with price, sales, revenue and global market share of Dermatomyositis Drug in 2018 and 2019.
Chapter 3, the Dermatomyositis Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatomyositis Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Dermatomyositis Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Dermatomyositis Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Dermatomyositis Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dermatomyositis Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Abatacept
1.2.3 Baricitinib
1.2.4 Dalazatide
1.2.5 Immune Globulin
1.2.6 IMO-8400
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Dermatomyositis Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Dermatomyositis Drug Market
1.4.1 Global Dermatomyositis Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 MedImmune LLC
2.1.1 MedImmune LLC Details
2.1.2 MedImmune LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 MedImmune LLC SWOT Analysis
2.1.4 MedImmune LLC Product and Services
2.1.5 MedImmune LLC Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hope Pharmaceuticals Inc
2.2.1 Hope Pharmaceuticals Inc Details
2.2.2 Hope Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Hope Pharmaceuticals Inc SWOT Analysis
2.2.4 Hope Pharmaceuticals Inc Product and Services
2.2.5 Hope Pharmaceuticals Inc Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Octapharma AG
2.3.1 Octapharma AG Details
2.3.2 Octapharma AG Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Octapharma AG SWOT Analysis
2.3.4 Octapharma AG Product and Services
2.3.5 Octapharma AG Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Neovacs SA
2.4.1 Neovacs SA Details
2.4.2 Neovacs SA Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Neovacs SA SWOT Analysis
2.4.4 Neovacs SA Product and Services
2.4.5 Neovacs SA Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 F. Hoffmann-La Roche Ltd
2.5.1 F. Hoffmann-La Roche Ltd Details
2.5.2 F. Hoffmann-La Roche Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 F. Hoffmann-La Roche Ltd SWOT Analysis
2.5.4 F. Hoffmann-La Roche Ltd Product and Services
2.5.5 F. Hoffmann-La Roche Ltd Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis AG
2.6.1 Novartis AG Details
2.6.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis AG SWOT Analysis
2.6.4 Novartis AG Product and Services
2.6.5 Novartis AG Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 KPI Therapeutics Inc
2.7.1 KPI Therapeutics Inc Details
2.7.2 KPI Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 KPI Therapeutics Inc SWOT Analysis
2.7.4 KPI Therapeutics Inc Product and Services
2.7.5 KPI Therapeutics Inc Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly and Company
2.8.1 Eli Lilly and Company Details
2.8.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly and Company SWOT Analysis
2.8.4 Eli Lilly and Company Product and Services
2.8.5 Eli Lilly and Company Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer Inc
2.9.1 Pfizer Inc Details
2.9.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer Inc SWOT Analysis
2.9.4 Pfizer Inc Product and Services
2.9.5 Pfizer Inc Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Idera Pharmaceuticals Inc
2.10.1 Idera Pharmaceuticals Inc Details
2.10.2 Idera Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Idera Pharmaceuticals Inc SWOT Analysis
2.10.4 Idera Pharmaceuticals Inc Product and Services
2.10.5 Idera Pharmaceuticals Inc Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Marathon Pharmaceuticals LLC
2.11.1 Marathon Pharmaceuticals LLC Details
2.11.2 Marathon Pharmaceuticals LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Marathon Pharmaceuticals LLC SWOT Analysis
2.11.4 Marathon Pharmaceuticals LLC Product and Services
2.11.5 Marathon Pharmaceuticals LLC Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Dermatomyositis Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Dermatomyositis Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Dermatomyositis Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Dermatomyositis Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Dermatomyositis Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Dermatomyositis Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Dermatomyositis Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Dermatomyositis Drug Sales and Growth Rate (2015-2020)
4.3 Europe Dermatomyositis Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Dermatomyositis Drug Sales and Growth Rate (2015-2020)
4.5 South America Dermatomyositis Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Dermatomyositis Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Dermatomyositis Drug Sales, Revenue and Market Share by Country
5.1.1 North America Dermatomyositis Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Dermatomyositis Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Dermatomyositis Drug Sales and Growth Rate (2015-2020)
5.3 Canada Dermatomyositis Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Dermatomyositis Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Dermatomyositis Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Dermatomyositis Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Dermatomyositis Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Dermatomyositis Drug Sales and Growth Rate (2015-2020)
6.3 UK Dermatomyositis Drug Sales and Growth Rate (2015-2020)
6.4 France Dermatomyositis Drug Sales and Growth Rate (2015-2020)
6.5 Russia Dermatomyositis Drug Sales and Growth Rate (2015-2020)
6.6 Italy Dermatomyositis Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Dermatomyositis Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Dermatomyositis Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Dermatomyositis Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Dermatomyositis Drug Sales and Growth Rate (2015-2020)
7.3 Japan Dermatomyositis Drug Sales and Growth Rate (2015-2020)
7.4 Korea Dermatomyositis Drug Sales and Growth Rate (2015-2020)
7.5 India Dermatomyositis Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Dermatomyositis Drug Sales and Growth Rate (2015-2020)
7.7 Australia Dermatomyositis Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Dermatomyositis Drug Sales, Revenue and Market Share by Country
8.1.1 South America Dermatomyositis Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Dermatomyositis Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Dermatomyositis Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Dermatomyositis Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Dermatomyositis Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Dermatomyositis Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Dermatomyositis Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Dermatomyositis Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Dermatomyositis Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Dermatomyositis Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Dermatomyositis Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Dermatomyositis Drug Sales and Market Share by Type (2015-2020)
10.2 Global Dermatomyositis Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Dermatomyositis Drug Price by Type (2015-2020)
11 Global Dermatomyositis Drug Market Segment by Application
11.1 Global Dermatomyositis Drug Sales Market Share by Application (2015-2020)
11.2 Global Dermatomyositis Drug Revenue Market Share by Application (2015-2020)
11.3 Global Dermatomyositis Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Dermatomyositis Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Dermatomyositis Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Dermatomyositis Drug Market Forecast (2021-2025)
12.2.2 Europe Dermatomyositis Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Dermatomyositis Drug Market Forecast (2021-2025)
12.2.4 South America Dermatomyositis Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Dermatomyositis Drug Market Forecast (2021-2025)
12.3 Dermatomyositis Drug Market Forecast by Type (2021-2025)
12.3.1 Global Dermatomyositis Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Dermatomyositis Drug Market Share Forecast by Type (2021-2025)
12.4 Dermatomyositis Drug Market Forecast by Application (2021-2025)
12.4.1 Global Dermatomyositis Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Dermatomyositis Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Dermatomyositis Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Dermatomyositis Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Dermatomyositis Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. MedImmune LLC Basic Information, Manufacturing Base and Competitors
Table 8. MedImmune LLC Dermatomyositis Drug Major Business
Table 9. MedImmune LLC Dermatomyositis Drug Total Revenue (USD Million) (2018-2019)
Table 10. MedImmune LLC SWOT Analysis
Table 11. MedImmune LLC Dermatomyositis Drug Product and Services
Table 12. MedImmune LLC Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Hope Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 14. Hope Pharmaceuticals Inc Dermatomyositis Drug Major Business
Table 15. Hope Pharmaceuticals Inc Dermatomyositis Drug Total Revenue (USD Million) (2018-2019)
Table 16. Hope Pharmaceuticals Inc SWOT Analysis
Table 17. Hope Pharmaceuticals Inc Dermatomyositis Drug Product and Services
Table 18. Hope Pharmaceuticals Inc Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Octapharma AG Basic Information, Manufacturing Base and Competitors
Table 20. Octapharma AG Dermatomyositis Drug Major Business
Table 21. Octapharma AG Dermatomyositis Drug Total Revenue (USD Million) (2018-2019)
Table 22. Octapharma AG SWOT Analysis
Table 23. Octapharma AG Dermatomyositis Drug Product and Services
Table 24. Octapharma AG Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Neovacs SA Basic Information, Manufacturing Base and Competitors
Table 26. Neovacs SA Dermatomyositis Drug Major Business
Table 27. Neovacs SA Dermatomyositis Drug Total Revenue (USD Million) (2018-2019)
Table 28. Neovacs SA SWOT Analysis
Table 29. Neovacs SA Dermatomyositis Drug Product and Services
Table 30. Neovacs SA Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 32. F. Hoffmann-La Roche Ltd Dermatomyositis Drug Major Business
Table 33. F. Hoffmann-La Roche Ltd Dermatomyositis Drug Total Revenue (USD Million) (2018-2019)
Table 34. F. Hoffmann-La Roche Ltd SWOT Analysis
Table 35. F. Hoffmann-La Roche Ltd Dermatomyositis Drug Product and Services
Table 36. F. Hoffmann-La Roche Ltd Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 38. Novartis AG Dermatomyositis Drug Major Business
Table 39. Novartis AG Dermatomyositis Drug Total Revenue (USD Million) (2018-2019)
Table 40. Novartis AG SWOT Analysis
Table 41. Novartis AG Dermatomyositis Drug Product and Services
Table 42. Novartis AG Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. KPI Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 44. KPI Therapeutics Inc Dermatomyositis Drug Major Business
Table 45. KPI Therapeutics Inc Dermatomyositis Drug Total Revenue (USD Million) (2018-2019)
Table 46. KPI Therapeutics Inc SWOT Analysis
Table 47. KPI Therapeutics Inc Dermatomyositis Drug Product and Services
Table 48. KPI Therapeutics Inc Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 50. Eli Lilly and Company Dermatomyositis Drug Major Business
Table 51. Eli Lilly and Company Dermatomyositis Drug Total Revenue (USD Million) (2018-2019)
Table 52. Eli Lilly and Company SWOT Analysis
Table 53. Eli Lilly and Company Dermatomyositis Drug Product and Services
Table 54. Eli Lilly and Company Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 56. Pfizer Inc Dermatomyositis Drug Major Business
Table 57. Pfizer Inc Dermatomyositis Drug Total Revenue (USD Million) (2018-2019)
Table 58. Pfizer Inc SWOT Analysis
Table 59. Pfizer Inc Dermatomyositis Drug Product and Services
Table 60. Pfizer Inc Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Idera Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 62. Idera Pharmaceuticals Inc Dermatomyositis Drug Major Business
Table 63. Idera Pharmaceuticals Inc Dermatomyositis Drug Total Revenue (USD Million) (2018-2019)
Table 64. Idera Pharmaceuticals Inc SWOT Analysis
Table 65. Idera Pharmaceuticals Inc Dermatomyositis Drug Product and Services
Table 66. Idera Pharmaceuticals Inc Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Marathon Pharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table 68. Marathon Pharmaceuticals LLC Dermatomyositis Drug Major Business
Table 69. Marathon Pharmaceuticals LLC Dermatomyositis Drug Total Revenue (USD Million) (2018-2019)
Table 70. Marathon Pharmaceuticals LLC SWOT Analysis
Table 71. Marathon Pharmaceuticals LLC Dermatomyositis Drug Product and Services
Table 72. Marathon Pharmaceuticals LLC Dermatomyositis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Dermatomyositis Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 74. Global Dermatomyositis Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Dermatomyositis Drug Sales by Regions (2015-2020) (K Pcs)
Table 76. Global Dermatomyositis Drug Sales Market Share by Regions (2015-2020)
Table 77. Global Dermatomyositis Drug Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Dermatomyositis Drug Sales by Countries (2015-2020) (K Pcs)
Table 79. North America Dermatomyositis Drug Sales Market Share by Countries (2015-2020)
Table 80. North America Dermatomyositis Drug Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Dermatomyositis Drug Revenue Market Share by Countries (2015-2020)
Table 82. Europe Dermatomyositis Drug Sales by Countries (2015-2020) (K Pcs)
Table 83. Europe Dermatomyositis Drug Sales Market Share by Countries (2015-2020)
Table 84. Europe Dermatomyositis Drug Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Dermatomyositis Drug Sales by Regions (2015-2020) (K Pcs)
Table 86. Asia-Pacific Dermatomyositis Drug Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Dermatomyositis Drug Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Dermatomyositis Drug Sales by Countries (2015-2020) (K Pcs)
Table 89. South America Dermatomyositis Drug Sales Market Share by Countries (2015-2020)
Table 90. South America Dermatomyositis Drug Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Dermatomyositis Drug Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Dermatomyositis Drug Sales by Countries (2015-2020) (K Pcs)
Table 93. Middle East & Africa Dermatomyositis Drug Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Dermatomyositis Drug Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Dermatomyositis Drug Revenue Market Share by Countries (2015-2020)
Table 96. Global Dermatomyositis Drug Sales by Type (2015-2020) (K Pcs)
Table 97. Global Dermatomyositis Drug Sales Share by Type (2015-2020)
Table 98. Global Dermatomyositis Drug Revenue by Type (2015-2020) (USD Million)
Table 99. Global Dermatomyositis Drug Revenue Share by Type (2015-2020)
Table 100. Global Dermatomyositis Drug Sales by Application (2015-2020) (K Pcs)
Table 101. Global Dermatomyositis Drug Sales Share by Application (2015-2020)
Table 102. Global Dermatomyositis Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 103. Global Dermatomyositis Drug Market Share Forecast by Regions (2021-2025)
Table 104. Global Dermatomyositis Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 105. Global Dermatomyositis Drug Market Share Forecast by Type (2021-2025)
Table 106. Global Dermatomyositis Drug Sales Forecast by Application (2021-2025)
Table 107. Global Dermatomyositis Drug Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Dermatomyositis Drug Picture
Figure 2. Global Sales Market Share of Dermatomyositis Drug by Type in 2019
Figure 3. Abatacept Picture
Figure 4. Baricitinib Picture
Figure 5. Dalazatide Picture
Figure 6. Immune Globulin Picture
Figure 7. IMO-8400 Picture
Figure 8. Others Picture
Figure 9. Dermatomyositis Drug Sales Market Share by Application in 2018
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Others Picture
Figure 13. Global Dermatomyositis Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Dermatomyositis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Dermatomyositis Drug Sales Market Share by Manufacturer in 2019
Figure 34. Global Dermatomyositis Drug Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Dermatomyositis Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Dermatomyositis Drug Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 39. Global Dermatomyositis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Dermatomyositis Drug Revenue Market Share by Regions (2015-2020)
Figure 41. Global Dermatomyositis Drug Revenue Market Share by Regions in 2018
Figure 42. North America Dermatomyositis Drug Sales and Growth Rate (2015-2020)
Figure 43. Europe Dermatomyositis Drug Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Dermatomyositis Drug Sales and Growth Rate (2015-2020)
Figure 45. South America Dermatomyositis Drug Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Dermatomyositis Drug Sales and Growth Rate (2015-2020)
Figure 47. North America Dermatomyositis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Dermatomyositis Drug Sales Market Share by Countries (2015-2020)
Figure 49. North America Dermatomyositis Drug Sales Market Share by Countries in 2018
Figure 50. North America Dermatomyositis Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Dermatomyositis Drug Revenue Market Share by Countries in 2018
Figure 52. United States Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Canada Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Mexico Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Europe Dermatomyositis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Dermatomyositis Drug Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Dermatomyositis Drug Revenue Market Share by Countries in 2019
Figure 58. Germany Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. UK Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. France Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Russia Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Italy Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Asia-Pacific Dermatomyositis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Dermatomyositis Drug Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Dermatomyositis Drug Revenue Market Share by Regions 2019
Figure 66. China Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Korea Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. India Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Southeast Asia Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. South America Dermatomyositis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Dermatomyositis Drug Sales Market Share by Countries in 2019
Figure 73. South America Dermatomyositis Drug Revenue Market Share by Countries in 2019
Figure 74. Brazil Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Argentina Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Middle East and Africa Dermatomyositis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Dermatomyositis Drug Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Dermatomyositis Drug Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Dermatomyositis Drug Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Egypt Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Turkey Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. South Africa Dermatomyositis Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Global Dermatomyositis Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 85. Global Dermatomyositis Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Dermatomyositis Drug Market Forecast (2021-2025) (K Pcs)
Figure 87. Europe Sales Dermatomyositis Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. Asia-Pacific Sales Dermatomyositis Drug Market Forecast (2021-2025) (K Pcs)
Figure 89. South America Sales Dermatomyositis Drug Market Forecast (2021-2025) (K Pcs)
Figure 90. Middle East & Africa Sales Dermatomyositis Drug Market Forecast (2021-2025) (K Pcs)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
アンカ血管炎薬の世界市場 2020年 Market Overview The global Anca Vasculitis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anca Vasculitis Drug mar…- 甲状腺機能低下症治療の世界市場 2020年 Market Overview The global Hypothyroidism Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hypothyroidism Drug marke…
- 未分化甲状腺がん治療薬の世界市場 2020年 Market Overview The global Anaplastic Thyroid Cancer Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anaplastic Thy…
- 小売用医薬品の世界市場 2020年 Market Overview The global Retail Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.8% in the forecast period of 2020 to 2025 and will expected to reach USD 1350.1 million by 2025, from USD 1211 million in 2019. The Retail Drug market report …
- スニチニブ薬の世界市場 2020年 Market Overview The global Sunitinib Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sunitinib Drug market report p…